Neuropathic Pain Drugs Market to Reach $18.7 Billion by 2032 with 7.9% CAGR Growth The global Neuropathic Pain Drugs market is expanding steadily, driven by rising prevalence of chronic neurological disorders and aging populations. Valued at approximately $9.6 billion in 2023, the market is projected to grow at a CAGR of 7.9% from 2024 to 2032. By 2025, over 32% of chronic pain patients are expected to be treated with neuropathic pain drugs, compared to 24% in 2020, reflecting increasing diagnosis and treatment rates. Read Full Research Study: https://marketintelo.com/report/neuropathic-pain-drugs-market